RESUMEN
<p><b>OBJECTIVES</b>To investigate the relationship of the transforming growth factor beta1 (TGF-β1) mRNA expression in atrial myocardium and the effectiveness of radiofrequency Maze procedure in patients with rheumatic valvular disease (RHD) and permanent atrial fibrillation (AF).</p><p><b>METHODS</b>Between January 2008 and September 2008, 40 patients with RHD and AF underwent a radiofrequency Maze procedure with concomitant valvular surgery. The patients were assigned to normal sinus rhythm (SR) group (group A) and persistence AF group (group B) according to the results of the 6-month follow-up. Another 10 patients with SR and RHD undergone valvular surgery alone were assigned to control group (group C). Left atrial appendage were obtained in all patients. Expressions of TGF-β1 mRNA were detected by semiquantitative RT-PCR technique. CVF-I and CVF-III were observed by sirius red staining.</p><p><b>RESULTS</b>At 6-month follow-up, there were 28 patients in group A and 12 in group B. Patients in group A and group B had higher mRNA expressions of TGF-β1, CVF-I and CVF-I/CVF-III compared with group C (P < 0.05). Also, the group B had higher mRNA expressions of TGF-β1, CVF-I and CVF-I/CVF-III than group A (P < 0.05). The patients who had return of functional atrial contraction in group A had lower mRNA expression than the non-return patients (39 ± 12 vs. 60 ± 12, P < 0.05). The TGF-β1 mRNA expression had a correlation with both the contents of CVF-I and left atrial diameter (r = 0.786, P < 0.05; r = 0.858, P < 0.05). Multiple logistic regression analysis revealed that the risk factors which independently associated with the postoperative persistence of atrial fibrillation at 6-month follow-up includes mRNA expression levels of TGF-β1 (OR = 1.13, 95%CI 1.05 - 1.18, P = 0.031), CVF-I (OR = 1.07, 95%CI 1.00 - 1.13, P = 0.037) and lett atrial diameter (OR = 2.23, 95%CI 1.08 - 4.59, P = 0.042).</p><p><b>CONCLUSIONS</b>The atrial TGF-β1 mRNA expression level could predict the persistence of AF and the return of the functional atrial contraction at 6-month follow-up in patients who underwent rheumatic valvular surgery and concomitant radiofrequency Maze procedure.</p>
Asunto(s)
Humanos , Fibrilación Atrial , Metabolismo , Cirugía General , Ablación por Catéter , Estudios de Seguimiento , Atrios Cardíacos , Metabolismo , Cardiopatía Reumática , Factor de Crecimiento Transformador beta1 , Metabolismo , Resultado del TratamientoRESUMEN
<p><b>OBJECTIVE</b>To investigate the heavy metals (HMs) and polycyclic aromatic hydrocarbons (PAHs) in sludge of twelve wastewater treatment plants (WWTPs) in Zhejiang province of China, and to assess their potential for land application.</p><p><b>METHODS</b>Sludge was collected from 12 WWTPs within the province. GC-MS and AAS were used to measure PAHs and HMs contents in sludge.</p><p><b>RESULTS</b>Concentrations of HMs in most of the sludge samples were below the regulatory limits for the sludge to be used in agriculture in China with the exception of Zn in 2 sludge samples and Cd in 1 sample. All 16 PAHs, targeted by the USEPA agency, were found in the sludge from the twelve plants with a total concentration ranging from 33.73 mg kg(-1) to 82.58 mg kg(-1) (dry weight, d.w.). The levels of Sigma9 PAHs varied from 13.87 mg kg(-1) to 61.86 mg kg(-1) (d.w.) in the sludge, far exceeding the limitation value recommended by the Europe Union. The concentration and composition of PAHs in sewage sludge varied and depended mainly on the quantity and type of industrial wastewater accepted by the WWTPs. A significant relationship between the proportion of industrial wastewater received by WWTPs and the total content of 16 PAHs in the sludge was observed.</p><p><b>CONCLUSION</b>PAHs have become one of the primary pollutants in sludge of Zhejiang WWTPs instead of HMs. It is, therefore, essential to reduce the contents of PAHs before the sludge can be used in agriculture through proper treatment.</p>